Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lyra Therapeutics Inc
(NQ:
LYRA
)
0.3019
-0.0198 (-6.15%)
Streaming Delayed Price
Updated: 2:33 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Lyra Therapeutics Inc
Lyra Therapeutics Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for LYR-210 for the Treatment of Chronic Rhinosinusitis
June 08, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets
June 02, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics to Present at the William Blair 41st Annual Growth Stock Conference
June 01, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics To Present At The Jefferies Virtual Healthcare Conference
May 24, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 11, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics to Present at the BofA Securities 2021 Virtual Health Care Conference
May 06, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update
April 27, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual
April 11, 2021
From
Lyra Therapeutics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.